用户48783635432019-04-09 14:29
【汇众医疗】Navidea宣布重启NAV3-31的2b期临床试验,此后股价上升13%
$Navidea生物制药(NAVB)$ Navidea根据FDA的反馈,宣布重启对NAV3-31的2b期临床试验计划,评估成像剂Tc99m tilmanocept在类风湿性关节炎患者中的应用。此举促进该公司股价上升了13%。 查看全文网页链接查看全文
艾萨克的猫2018-10-23 23:00
$Navidea Biopharmaceuticals, Inc. (NAVB)$ Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced today the company will pr...查看全文
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 美东时间 2015-03-05 08:30 Q4 2014 Navidea Biopharmaceuticals Inc Earnings Call 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 美东时间 2015-02-09 10:00 Navidea Biopharmaceuticals Inc at Biotechnology Industry Organization CEO & Investor Conference 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 美东时间 2015-01-13 17:30 Navidea Biopharmaceuticals Inc at EBD Biotech Showcase 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 美东时间 2014-12-04 11:30 Navidea Biopharmaceuticals Inc at LD Micro Conference 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 美东时间 2014-11-06 09:00 Before Open:NAVIDEA BIOPHAR Earning Release 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 美东时间 2014-11-06 08:30 Q3 2014 Navidea Biopharmaceuticals Inc Earnings Call 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 内部交易: 2014-09-02,10% Owner,Nordlicht Mark ,卖出,60000普通股, $1.36
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 美东时间 2014-08-06 09:00 Before Open:NAVIDEA BIOPHAR Earning Release 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 美东时间 2014-08-06 08:30 Q2 2014 Navidea Biopharmaceuticals Inc Earnings Call 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 美东时间 2014-07-17 09:00 Navidea Biopharmaceuticals Inc Annual Shareholders Meeting 网页链接